Autoimmune encephalitis: the first observational study from Iran.

Etemadifar, Masoud; Aghababaei, Ali; Nouri, Hosein; Kargaran, Parisa K; Mohammadi, Shaghayegh; Salari, Mehri

Etemadifar, Masoud; Aghababaei, Ali; Nouri, Hosein; Kargaran, Parisa K; Mohammadi, Shaghayegh; Salari, Mehri.

Affiliation

Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Aghababaei A; Al-Zahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Nouri H; Al-Zahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. aaghababaei78@gmail.com.
Kargaran PK; Al-Zahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammadi S; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran.
Salari M; Department of Cardiovascular Medicine, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA.

Neurol Sci ; 43(2): 1239-1248, 2022 Feb.

Article in En | MEDLINE | ID: mdl-34328580

Subject(s)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Hashimoto Disease; Adult; Autoantibodies; Cross-Sectional Studies; Female; Hashimoto Disease/diagnosis; Hashimoto Disease/epidemiology; Humans; Iran/epidemiology; Middle Aged; Young Adult

Key words

Autoantibodies; Autoimmune encephalitis; Parkinsonism; Stiff-person syndrome; Systemic lupus erythematosus; Zic4

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hashimoto Disease / Anti-N-Methyl-D-Aspartate Receptor Encephalitis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Iran

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google